ESC 2019 — Updated cholesterol guidelines: go for a new low in LDL-C


  • Emily Willingham, PhD
  • Conference Reports
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • “Go as low as you can go” when it comes to low-density lipoprotein cholesterol (LDL-C) measures, per the latest European Society of Cardiology (ESC) dyslipidemia guidelines.
  • That mantra applies especially in patients with high or very high cardiovascular disease (CVD) risk, say guidelines authors, with a recommended target
  • Full guidelines are available here; clinicians can get a pocket version here or via the ESC mobile pocket guidelines app .

Why this matters

  • The evidence is now “overwhelming” that high LDL-C “is a potent cause of heart attack and stroke,” said Colin Baigent, guidelines task force chair, in a statement. 
  • Risk for CVD falls regardless of starting LDL-C concentrations, he said, so that people with high or very high CVD risk can benefit from LDL-C reductions, even with below-average baseline levels.
  • “There is no lower limit of LDL cholesterol that is known to be unsafe,” the guidelines state.

Key highlights

  • New additions to the guidelines are listed here.
    • New LDL-C target  
    • Statins are recommended (class I) for primary prevention according to risk level in people age 75 years or less.
  • Changes from 2016 guidelines are listed here. 
  • A treatment algorithm is provided for pharmacological reduction of LDL-C. 
  • The guidelines include a list of what to do and what not to do. 
    • Among them: because of a lack of formal safety studies, statins are not recommended for women who might become pregnant.
    • Fish oil supplements make the “do” list if added to a statin for hypertriglyceridemia that persists under statin therapy.

Additional note

 

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit